TY - JOUR
T1 - A 7-year consecutive study on salivary duct carcinoma of the parotid gland
T2 - An institutional review
AU - Sato, Kaname
AU - Taguchi, Takahide
AU - Kitani, Yuka
AU - Tanaka, Yasuko
AU - Takahashi, Hideaki
AU - Arai, Yasuhiro
AU - Sano, Daisuke
AU - Komatsu, Masanori
AU - Nishimura, Goshi
AU - Takahashi, Masahiro
AU - Oridate, Nobuhiko
PY - 2014
Y1 - 2014
N2 - Salivary duct carcinoma (SDC) is considered to be a high-grade malignant tumor with morphological resemblance to invasive ductal carcinoma of the breast, and develops high mortality. We retrospectively investigated the outcomes of 7 SDC cases (1 stageI, 1 stageII and 5 stageIVa) treated in Yokohama City University from 2003 to 2011. The treatment consisted of definitive surgery, postoperative concurrent chemoradiotherapy and adjuvant chemotherapy. The five-year disease specific survival rate was 83.3%, which was better than those of previous reports. Our multidisciplinary regimen might be an effective therapeutic option for SDC.
AB - Salivary duct carcinoma (SDC) is considered to be a high-grade malignant tumor with morphological resemblance to invasive ductal carcinoma of the breast, and develops high mortality. We retrospectively investigated the outcomes of 7 SDC cases (1 stageI, 1 stageII and 5 stageIVa) treated in Yokohama City University from 2003 to 2011. The treatment consisted of definitive surgery, postoperative concurrent chemoradiotherapy and adjuvant chemotherapy. The five-year disease specific survival rate was 83.3%, which was better than those of previous reports. Our multidisciplinary regimen might be an effective therapeutic option for SDC.
KW - Adjuvant chemotherapy
KW - Carcinoma of parotid gland
KW - Postoperative chemoradiotherapy
KW - Salivary duct carcinoma
KW - Salivary gland carcinoma
UR - http://www.scopus.com/inward/record.url?scp=84899651981&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84899651981&partnerID=8YFLogxK
U2 - 10.5981/jjhnc.40.71
DO - 10.5981/jjhnc.40.71
M3 - Article
AN - SCOPUS:84899651981
SN - 1349-5747
VL - 40
SP - 71
EP - 74
JO - Japanese Journal of Head and Neck Cancer
JF - Japanese Journal of Head and Neck Cancer
IS - 1
ER -